BioLargo (BLGO) Competitors $0.18 0.00 (-0.28%) (As of 12:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends BLGO vs. AMTX, ORGN, VGAS, CBUS, ALTO, TLGY, LODE, LOOP, FSI, and CGAShould you be buying BioLargo stock or one of its competitors? The main competitors of BioLargo include Aemetis (AMTX), Origin Materials (ORGN), Verde Clean Fuels (VGAS), Cibus (CBUS), Alto Ingredients (ALTO), TLGY Acquisition (TLGY), Comstock (LODE), Loop Industries (LOOP), Flexible Solutions International (FSI), and China Green Agriculture (CGA). These companies are all part of the "chemicals" industry. BioLargo vs. Aemetis Origin Materials Verde Clean Fuels Cibus Alto Ingredients TLGY Acquisition Comstock Loop Industries Flexible Solutions International China Green Agriculture Aemetis (NASDAQ:AMTX) and BioLargo (NASDAQ:BLGO) are both small-cap oils/energy companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk, media sentiment and community ranking. Which has higher earnings and valuation, AMTX or BLGO? BioLargo has lower revenue, but higher earnings than Aemetis. BioLargo is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAemetis$186.72M1.07-$46.42M-$2.26-1.77BioLargo$12.23M4.35-$3.50M-$0.01-17.69 Does the MarketBeat Community prefer AMTX or BLGO? Aemetis received 67 more outperform votes than BioLargo when rated by MarketBeat users. However, 60.99% of users gave BioLargo an outperform vote while only 60.14% of users gave Aemetis an outperform vote. CompanyUnderperformOutperformAemetisOutperform Votes17860.14% Underperform Votes11839.86% BioLargoOutperform Votes11160.99% Underperform Votes7139.01% Do analysts prefer AMTX or BLGO? Aemetis currently has a consensus price target of $12.95, indicating a potential upside of 223.75%. Given Aemetis' stronger consensus rating and higher possible upside, analysts clearly believe Aemetis is more favorable than BioLargo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aemetis 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, AMTX or BLGO? Aemetis has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, BioLargo has a beta of 0.2, suggesting that its stock price is 80% less volatile than the S&P 500. Do institutionals & insiders hold more shares of AMTX or BLGO? 27.0% of Aemetis shares are held by institutional investors. Comparatively, 0.0% of BioLargo shares are held by institutional investors. 15.9% of Aemetis shares are held by insiders. Comparatively, 20.3% of BioLargo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is AMTX or BLGO more profitable? BioLargo has a net margin of -11.45% compared to Aemetis' net margin of -33.21%. Aemetis' return on equity of 0.00% beat BioLargo's return on equity.Company Net Margins Return on Equity Return on Assets Aemetis-33.21% N/A -40.11% BioLargo -11.45%-39.90%-22.06% Does the media refer more to AMTX or BLGO? In the previous week, Aemetis had 3 more articles in the media than BioLargo. MarketBeat recorded 6 mentions for Aemetis and 3 mentions for BioLargo. Aemetis' average media sentiment score of 0.75 beat BioLargo's score of 0.45 indicating that Aemetis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aemetis 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioLargo 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAemetis beats BioLargo on 11 of the 18 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get BioLargo News Delivered to You Automatically Sign up to receive the latest news and ratings for BLGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLGO vs. The Competition Export to ExcelMetricBioLargoChemicals & allied products IndustryConstruction SectorNASDAQ ExchangeMarket Cap$53.24M$4.18B$10.03B$8.79BDividend YieldN/A2.87%1.82%4.07%P/E Ratio-17.6912.5827.4914.02Price / Sales4.3524.733.4887.41Price / CashN/A10.9921.4636.27Price / Book8.852.684.996.33Net Income-$3.50M$244.18M$515.90M$225.71M7 Day Performance-10.88%0.25%0.99%-0.58%1 Month Performance-26.29%-2.60%1.89%1.49%1 Year Performance4.18%14.05%48.59%27.23% BioLargo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLGOBioLargoN/A$0.18-0.3%N/A+10.9%$53.24M$12.23M-17.6930AMTXAemetis2.0129 of 5 stars$4.00+3.4%$12.95+223.8%-20.8%$198.96M$186.72M0.00160ORGNOrigin Materials3.351 of 5 stars$1.19+15.5%$3.00+152.2%+5.1%$173.38M$28.81M-2.02160Insider TradeGap UpVGASVerde Clean Fuels0.4876 of 5 stars$4.15-0.2%N/A+23.4%$133.01MN/A-8.322Positive NewsGap UpCBUSCibus2.7897 of 5 stars$4.21+6.0%$22.83+442.4%-67.7%$111.40M$1.82M-0.18183ALTOAlto Ingredients3.4465 of 5 stars$1.45+4.0%$5.50+280.6%-40.9%$110.76M$1.22B0.00420TLGYTLGY AcquisitionN/A$11.65+0.3%N/A+5.5%$110.33MN/A0.003Positive NewsLODEComstock1.8305 of 5 stars$0.34-1.7%$2.60+661.1%-26.1%$71.91M$1.86M-2.9030News CoverageLOOPLoop IndustriesN/A$1.30+3.8%N/A-64.2%$61.91M$150,000.000.0090FSIFlexible Solutions InternationalN/A$3.96+0.3%N/A+136.1%$49.34M$38.33M11.8840Analyst RevisionCGAChina Green Agriculture0.5577 of 5 stars$2.01+2.6%N/A-4.4%$29.73M$95.85M-0.97424Analyst ForecastNews CoverageGap Down Related Companies and Tools Related Companies AMTX Competitors ORGN Competitors VGAS Competitors CBUS Competitors ALTO Competitors TLGY Competitors LODE Competitors LOOP Competitors FSI Competitors CGA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BLGO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLargo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLargo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
